Tag: Diabetes Drugs: Bydureon Byetta Janumet Januvia Victoza

Oklahoma Byetta Lawsuit

Diabetes Drug Lawsuits Claim Serious Risks for Oklahoma Patients

Could You Have a Diabetes Drug Lawsuit in Oklahoma? Based on recent studies, thousands of individuals across Oklahoma may have been exposed to the risks of diabetes medications. […]

Oklahoma Januvia Lawyer

Oklahoma Januvia Lawyers Discuss Risks of Januvia

          (To view full size image, click the image or click here.) A once-daily pill that controls type 2 diabetes patients’ blood sugar levels, […]

Oklahoma Byetta Lawyer

Should You Seek Help From an Oklahoma Byetta Lawyer?

(To view full size image, click the image or click here.) Although patients across the country have successfully taken Byetta with little or no reports of complications or […]

Oklahoma Victoza Lawyer

Oklahoma Victoza Lawyers Warn Consumers of Dangers of Victoza

(To view full size image, click the image or click here.) Victoza, a medication prescribed to type 2 diabetes patients to help them to better control their blood […]

Oklahoma Byetta Lawsuit

Could You Be Eligible for an Oklahoma Victoza Lawsuit?

Although Victoza has successfully helped type 2 diabetes patients across the globe, others are filing lawsuits against the drug’s manufacturer, Novo Nordisk, alleging serious and life-threatening complications such […]

Oklahoma Janumet Lawsuit Attorney

Could You Be Eligible for an Oklahoma Januvia Lawsuit?

Sitagliptin, more commonly known as Januvia, first received approval by the U.S. Food and Drug Administration (FDA) in October 2006. While the medication has reportedly helped those living […]

Oklahoma Janumet Lawsuit Attorney

Oklahoma Janumet Lawsuit Attorneys Explain Janumet Lawsuits

Janumet is a combination of metflorim and sitagliptin and is designed to help those living with type 2 diabetes to better manage their conditions. While many have taken […]

Oklahoma Byetta Lawsuit

Could You Be Eligible for an Oklahoma Byetta Lawsuit?

Byetta, a prescription medication for type 2 diabetes patients, was initially approved in April 2005 by the U.S. Food and Drug Administration (FDA). Although many have taken Byetta […]